Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma
Work
Year: 2020
Type: article
Abstract: The impact of bridging therapy (BT) administered between leukapheresis and chimeric antigen receptor (CAR) T-cell therapy for large B-cell lymphoma (LBCL) is unclear. We evaluated the influence of BT... more
Source: Blood Advances
Authors Chelsea C. Pinnix, Jillian R. Gunther, Bouthaina S. Dabaja, Paolo Strati, Penny Fang +14 more
Cites: 26
Cited by: 189
Related to: 10
FWCI: 12.67
Citation percentile (by year/subfield): 100
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal No poverty
Open Access status: gold
APC paid (est): $3,000